Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

4 Résultats
authFullName_s : Pascal Lenain
Image document

Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma

Anais Schavgoulidze , Valérie Lauwers-Cances , Aurore Perrot , Titouan Cazaubiel , Marie-Lorraine Chretien , et al.
Haematologica, 2023, 108 (5), pp.1374. ⟨10.3324/haematol.2021.280566⟩
Article dans une revue hal-03801805v1

Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience

Alexis Caulier , Murielle Roussel , Pierre Morel , Naelle Lombion , Benoit Branco , et al.
Blood, 2021, 138 (25), pp.2686-2695. ⟨10.1182/blood.2021011285⟩
Article dans une revue hal-03578209v1

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau , Michel Attal , Cyrille Hulin , Bertrand Arnulf , Karim Belhadj , et al.
The Lancet, 2019, 394 (10192), pp.29-38. ⟨10.1016/S0140-6736(19)31240-1⟩
Article dans une revue hal-03605015v1

Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial

Francois Guilhot , Françoise Rigal-Huguet , Joëlle Guilhot , Agnès-Paule Guerci-Bresler , Frédéric Maloisel , et al.
Article dans une revue hal-03122967v1